Valuation: Haleon plc

Capitalization 3.3TCr 4.46TCr 3.81TCr 3.55TCr 6.1TCr 3,82300Cr 6.78TCr 43TCr 16TCr 1,79000Cr 17TCr 16TCr 6,56600Cr P/E ratio 2025 *
21.2x
P/E ratio 2026 * 19.3x
Enterprise value 4.05TCr 5.47TCr 4.67TCr 4.35TCr 7.48TCr 4,69100Cr 8.32TCr 52TCr 20TCr 2,19600Cr 21TCr 20TCr 8,05600Cr EV / Sales 2025 *
3.64x
EV / Sales 2026 * 3.44x
Free-Float
89.25%
Yield 2025 *
1.88%
Yield 2026 * 2.1%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.29%
1 week-2.78%
Current month-1.87%
1 month-7.76%
3 months-1.90%
6 months-1.16%
Current year-2.65%
More quotes
1 week 366.8
Extreme 366.8
379
1 month 366.8
Extreme 366.8
399.8
Current year 354.2
Extreme 354.2
419.5
1 year 329.5
Extreme 329.5
419.5
3 years 241.17
Extreme 241.1735
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 22/07/2021
Director of Finance/CFO 55 01/11/2024
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 58 23/05/2022
Director/Board Member 70 18/07/2022
Director/Board Member 58 18/07/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.29%-2.78%+9.51% - 4.46TCr
+0.30%+1.58%-15.11%+139.53% 71TCr
-0.50%+0.57%+4.81%-12.03% 38TCr
-1.31%+1.67%+13.27%+25.60% 34TCr
-3.64%-2.74%-54.62%+8.25% 31TCr
-2.36%-1.23%+1.86%-21.34% 26TCr
-3.00%-1.93%-3.07%+15.94% 24TCr
-1.66%+1.10%-13.64%-6.31% 22TCr
-0.79%+3.00%-35.36%-11.60% 21TCr
-1.70%-1.00%-9.17%+19.17% 16TCr
Average -1.45%+0.22%-10.15%+17.47% 28.62TCr
Weighted average by Cap. -1.25%+0.59%-11.45%+36.74%
See all sector performances

Financials

2025 *2026 *
Net sales 1.11TCr 1.5TCr 1.28TCr 1.2TCr 2.06TCr 1,28900Cr 2.29TCr 14TCr 5.48TCr 60TCr 5.63TCr 5.52TCr 2,21400Cr 1.16TCr 1.56TCr 1.34TCr 1.25TCr 2.14TCr 1,34200Cr 2.38TCr 15TCr 5.71TCr 63TCr 5.87TCr 5.75TCr 2,30500Cr
Net income 159.92Cr 215.87Cr 184.59Cr 171.94Cr 295.49Cr 19TCr 328.38Cr 2.06TCr 787.71Cr 8.67TCr 809.62Cr 792.93Cr 32TCr 173.14Cr 233.71Cr 199.85Cr 186.15Cr 319.91Cr 20TCr 355.53Cr 2.23TCr 852.82Cr 9.39TCr 876.55Cr 858.48Cr 34TCr
Net Debt 749.25Cr 1.01TCr 864.83Cr 805.56Cr 1.38TCr 87TCr 1.54TCr 9.65TCr 3.69TCr 41TCr 3.79TCr 3.71TCr 1,49000Cr 684.65Cr 924.18Cr 790.27Cr 736.11Cr 1.27TCr 79TCr 1.41TCr 8.82TCr 3.37TCr 37TCr 3.47TCr 3.39TCr 1,36200Cr
More financial data * Estimated data
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,561
More about the company
Date Price Change Volume
11/25/11 367.40 p -1.29% 1,26,31,100
10/25/10 372.20 p +1.36% 3,16,08,140
09/25/09 367.20 p -1.08% 1,43,08,000
08/25/08 371.20 p -0.03% 2,68,72,060
07/25/07 371.30 p -1.75% 1,46,96,290

Delayed Quote London S.E., July 11, 2025 at 09:05 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.674GBP
Average target price
4.194GBP
Spread / Average Target
+14.16%
Consensus

Quarterly revenue - Rate of surprise